What does PHARMA STUBBE do?

PHARMA STUBBE is a pharmacy in Ingelmunster. Private Limited, started on 28 December 1992, 1 establishment.

What is the address of PHARMA STUBBE?

The registered office of PHARMA STUBBE is located at Kortrijkstraat 21, 8770 Ingelmunster.

Is PHARMA STUBBE still active?

Yes. According to the CBE (29 October 2026) PHARMA STUBBE is active, legal situation “Normale toestand”, started on 28 December 1992.

Is PHARMA STUBBE registered on Peppol?

Yes, PHARMA STUBBE is registered on the Peppol network with ID 0208:0448935794.

What is the enterprise number of PHARMA STUBBE?

The enterprise number of PHARMA STUBBE is BE0448935794.

When was PHARMA STUBBE founded?

PHARMA STUBBE was founded on 28 December 1992.

Who are the directors of PHARMA STUBBE?

According to the 2025 annual accounts, the directors of PHARMA STUBBE are: Katherine Stubbe.

Is PHARMA STUBBE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 December 1992; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMA STUBBE make in 2025?

PHARMA STUBBE posted a profit after taxes of € 14,813 in financial year 2025.

What is the revenue of PHARMA STUBBE?

As a small company, PHARMA STUBBE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 177,873.

How much does an employee at PHARMA STUBBE earn?

The average wage cost per full-time employee at PHARMA STUBBE was € 79,400 in 2025: staff costs of € 79,416 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMA STUBBE have?

According to the 2025 annual accounts, PHARMA STUBBE has 1 full-time equivalents (FTE).

Does PHARMA STUBBE have a website?

Yes, PHARMA STUBBE has a website at apstubbe.be.

PHARMA STUBBE (Private Limited) - Ingelmunster

Dossier PHARMA STUBBE, printed on 29 October 2026 from databakkes.be/en/0448935794/pharma-stubbe. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMA STUBBE from Ingelmunster, company number BE0448935794, closed financial year 2025 with a result of € 14,813 after tax. For that financial year PHARMA STUBBE recorded a gross margin of € 177,873 and equity of € 150,620. Compared with financial year 2024, the result moved from € 2,338 to € 14,813. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 11, 2026.

What it is worth Growing

€ 150,620

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 14,813

▲ € 12,475 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 104,964

▲ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 95,120.

People and assets in 2025

Full-time equivalents

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 79,416

▼ 4% vs 2024

€ 79,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,857

▼ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 200,583

▼ 19% vs 2024

€ 46,224 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 62,874

▲ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 25,059

▲ 20% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 155,713 Gross margin 2022: € 155,713 First fiscal year in the series	€ 158,927 Gross margin 2023: € 158,927 ▲ 2% vs 2022 (€ 155,713) Favourable step	€ 164,957 Gross margin 2024: € 164,957 ▲ 4% vs 2023 (€ 158,927) Favourable step	€ 177,873 Gross margin 2025: € 177,873 ▲ 8% vs 2024 (€ 164,957) Favourable step	▲ 8%
Profit after taxes	€ 16,542 Profit after taxes 2022: € 16,542 First fiscal year in the series	€ 11,002 Profit after taxes 2023: € 11,002 ▼ 33% vs 2022 (€ 16,542) Unfavourable step	€ 2,338 Profit after taxes 2024: € 2,338 ▼ 79% vs 2023 (€ 11,002) Unfavourable step	€ 14,813 Profit after taxes 2025: € 14,813 ▲ € 12,475 vs 2024 (€ 2,338) Favourable step	▲ € 12,475
Equity	€ 122,467 Equity 2022: € 122,467 First fiscal year in the series	€ 133,468 Equity 2023: € 133,468 ▲ 9% vs 2022 (€ 122,467) Favourable step	€ 135,806 Equity 2024: € 135,806 ▲ 2% vs 2023 (€ 133,468) Favourable step	€ 150,620 Equity 2025: € 150,620 ▲ 11% vs 2024 (€ 135,806) Favourable step	▲ 11%
Total debts	€ 481,567 Total debts 2022: € 481,567 First fiscal year in the series	€ 453,371 Total debts 2023: € 453,371 ▼ 6% vs 2022 (€ 481,567) Favourable step	€ 415,017 Total debts 2024: € 415,017 ▼ 8% vs 2023 (€ 453,371) Favourable step	€ 385,074 Total debts 2025: € 385,074 ▼ 7% vs 2024 (€ 415,017) Favourable step	▼ 7%
Cash	€ 58,614 Cash 2022: € 58,614 First fiscal year in the series	€ 63,369 Cash 2023: € 63,369 ▲ 8% vs 2022 (€ 58,614) Favourable step	€ 84,534 Cash 2024: € 84,534 ▲ 33% vs 2023 (€ 63,369) Favourable step	€ 104,964 Cash 2025: € 104,964 ▲ 24% vs 2024 (€ 84,534) Favourable step	▲ 24%
Land & buildings	€ 99,749 Land & buildings 2022: € 99,749 First fiscal year in the series	€ 85,429 Land & buildings 2023: € 85,429 ▼ 14% vs 2022 (€ 99,749) Unchanged	€ 69,584 Land & buildings 2024: € 69,584 ▼ 19% vs 2023 (€ 85,429) Unchanged	€ 54,506 Land & buildings 2025: € 54,506 ▼ 22% vs 2024 (€ 69,584) Unchanged	▼ 22%
Retained profit	€ 66,967 Retained profit 2022: € 66,967 First fiscal year in the series	€ 77,968 Retained profit 2023: € 77,968 ▲ 16% vs 2022 (€ 66,967) Favourable step	€ 80,306 Retained profit 2024: € 80,306 ▲ 3% vs 2023 (€ 77,968) Favourable step	€ 95,120 Retained profit 2025: € 95,120 ▲ 18% vs 2024 (€ 80,306) Favourable step	▲ 18%
Bank debt	€ 311,450 Bank debt 2022: € 311,450 First fiscal year in the series	€ 291,062 Bank debt 2023: € 291,062 ▼ 7% vs 2022 (€ 311,450) Favourable step	€ 246,150 Bank debt 2024: € 246,150 ▼ 15% vs 2023 (€ 291,062) Favourable step	€ 200,583 Bank debt 2025: € 200,583 ▼ 19% vs 2024 (€ 246,150) Favourable step	▼ 19%
Balance sheet total	€ 604,033 Balance sheet total 2022: € 604,033 First fiscal year in the series	€ 586,840 Balance sheet total 2023: € 586,840 ▼ 3% vs 2022 (€ 604,033) Unchanged	€ 550,824 Balance sheet total 2024: € 550,824 ▼ 6% vs 2023 (€ 586,840) Unchanged	€ 535,694 Balance sheet total 2025: € 535,694 ▼ 3% vs 2024 (€ 550,824) Unchanged	▼ 3%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	1.1 Employees (FTE) 2024: 1.1 ▲ 0.1 vs 2023 (1) Unchanged	1 Employees (FTE) 2025: 1 ▼ 0.1 vs 2024 (1.1) Unchanged	▼ 0.1

Key figures of PHARMA STUBBE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to PHARMA STUBBE?

What happened at PHARMA STUBBE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 11, 2026 New annual accounts for financial year 2025: profit of € 14,813 (▲ € 12,475 vs 2024). Source: NBB ↗
Mar 26, 1993 New establishment in Ingelmunster. KBO
Dec 28, 1992 Start of the company according to the CBE. KBO

In short

From € 16,542 profit in 2022 to € 14,813 profit in 2025.

Paid € 18,927 in corporate taxes since 2022.

Best year ever: 2022, with € 16,542 profit.

On average € 177,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Katherine Stubbe

PHARMA STUBBE

Behind PHARMA STUBBE is Katherine Stubbe.

Directors

According to the 2025 annual accounts

Katherine Stubbe

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kortrijkstraat 21

8770 Ingelmunster

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ECTECH

€ 34,112 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apstubbe.be

Technologies

AMPAlpine.jsCookie ConsentGoogle FontsGoogle TranslateMagentoNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

UPCLOUD, FI

Domain

apstubbe.be

Registered

2016-12-28

Website info

HTTPS Ja

Indexable pages 53,264

Languages NL

Features

Webshop Newsletter

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

Details

Company number

0448.935.794

VAT number

BE 0448.935.794

Registered office

Kortrijkstraat 21, 8770 Ingelmunster

Names & denominations

PHARMA STUBBE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 December 1992

Peppol

Active · Active since 26 Sept 2025

Contact

apstubbe.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMA STUBBE

Financials

What happened to PHARMA STUBBE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions